US BROKER MOVES: SIRI upgraded at Deutsche Bank; TOST downgraded at BNP

Daily broker-roundup wires of this kind are a standing feature of the US premarket, and their information content is well understood: single-name rating changes tend to matter only where they cluster thematically or where the house carrying the view has a franchise in the sector.

Newsquawk StaffPublished On the live feed at 9 more headlines followed before this page went public
Newsquawk headlinesUTC

Teva (TEVA) is targeting five regulatory submissions over five years, could collectively generate over USD 10bln in sales

US ADP Employment Change (Aug) 38K vs. Exp. 47K (Prev. 44K)

US BROKER MOVES: SIRI upgraded at Deutsche Bank; TOST downgraded at BNP

CrowdStrike (CRWD) has expanded its partnership with OpenAI to secure Codex agents and deploy GPT-5.6 Cyber on its Falcon

German Economy Ministry spokesperson says that gas storage is tighter than in previous years but there is no risk of gas shortages this winter

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

UPGRADES

  • GitLab (GTLB) Upgraded from Underperform to Market Perform at William Blair
  • Martin Marietta Materials (MLM) Upgraded from Neutral to Overweight at JPMorgan; PT USD 680
  • OGE Energy (OGE) Upgraded from Sector Perform to Outperform at RBC Capital; PT USD 54
  • Sirius XM (SIRI) Upgraded from Hold to Buy at Deutsche Bank; PT USD 45

DOWNGRADES

  • Amrize (AMRZ) Downgraded from Neutral to Underperform at BofA Securities; PT USD 40
  • Amrize (AMRZ) Downgraded from Overweight to Neutral at JPMorgan; PT USD 52
  • Comstock Resources (CRK) Downgraded from Buy to Neutral at Gerdes Energy Research; PT USD 16
  • Cenovus Energy (CVE) Downgraded from Buy to Neutral at Gerdes Energy Research; PT USD 50
  • EyePoint Pharmaceuticals (EYPT) Downgraded from Buy to Hold at TD Cowen; PT USD 4
  • Knife River (KNF) Downgraded from Neutral to Underweight at JPMorgan; PT USD 73
  • Toast (TOST) Downgraded from Outperform to Neutral at BNP Paribas Exane; PT USD 35

INITIATIONS

  • Almonty Industries (ALM) Initiated at Buy at Jefferies; PT USD 26.25
  • AST SpaceMobile (ASTS) Initiated at Buy at Berenberg; PT USD 92
  • AEVEX (AVEX) Initiated at Neutral at Piper Sandler; PT USD 20
  • Bilibili (BILI) Initiated at Buy at Zephirin Group; PT USD 21
  • BillionToOne (BLLN) Initiated at Buy at Canaccord; PT USD 120
  • Webull (BULL) Initiated at Sector Outperform at Scotiabank; PT USD 9
  • CareDx (CDNA) Initiated at Buy at Canaccord; PT USD 65
  • Chime Financial (CHYM) Initiated at Sector Outperform at Scotiabank; PT USD 40
  • CTS (CTS) Initiated at Buy at Lake Street; PT USD 67
  • Curtiss-Wright (CW) Initiated at Neutral at Piper Sandler; PT USD 665
  • Element Solutions (ESI) Initiated at Buy at Jefferies; PT USD 55
  • GFL Environmental (GFL) Initiated at Overweight at Barclays; PT USD 58
  • HawkEye 360 (HAWK) Initiated at Buy at Berenberg; PT USD 24
  • IperionX (IPX) Initiated at Buy at Jefferies; PT USD 26
  • Johnson & Johnson (JNJ) Initiated at Buy at UBS; PT USD 320
  • Mettler-Toledo (MTD) Initiated at Sell at Rothschild Redburn; PT USD 1,200
  • Materion (MTRN) Initiated at Buy at Jefferies; PT USD 314
  • NioCorp Developments (NB) Initiated at Hold at Jefferies; PT USD 4.70
  • Eagle Nuclear Energy (NUCL) Initiated at Buy at H.C. Wainwright; PT USD 11.50
  • Planet Labs (PL) Initiated at Buy at Berenberg; PT USD 25
  • uniQure (QURE) Initiated at Outperform at William Blair
  • Red Cat (RCAT) Initiated at Neutral at Piper Sandler; PT USD 9
  • REA (REA) Initiated at Hold at Jefferies; PT USD 12.30
  • Ring Energy (REI) Initiated at Neutral at Mizuho; PT USD 2
  • Rocket Lab (RKLB) Initiated at Buy at Berenberg; PT USD 83
  • Standard Lithium (SLI) Initiated at Hold at Jefferies; PT USD 2.90
  • Tempus AI (TEM) Initiated at Overweight at Cantor Fitzgerald; PT USD 80
  • USA Rare Earth (USAR) Initiated at Buy at Jefferies; PT USD 21
  • Xtant Medical (XTNT) Initiated at Buy at Lucid Capital Markets; PT USD 1
Context

The items that typically draw attention in a batch like this are the split views, and here Amrize carries dual downgrades from two houses to different rungs, a pattern that usually reflects a post-event rerating rather than independent discovery. Jefferies' cluster of initiations across rare earths, lithium and specialty materials reads as a coordinated sector launch, a sequence that has historically preceded follow-on research and corporate access rather than standing as isolated calls. The JPMorgan pair in construction materials, Martin Marietta up against Knife River down, is a relative-value stance within one coverage universe, the kind of internal rotation that tends to move the pair spread rather than the group. Initiations with Sell ratings, Mettler-Toledo here, are rarer than Buy launches and historically carry more signal given the institutional reluctance to open coverage negatively. Follow-ons worth noting are whether any of the downgraded names attract convergent calls from other houses in coming sessions, which is the usual mechanism by which a single rating change becomes a consensus shift.

Related headlines

The whole workspace, free to try.

Try it free